Loading clinical trials...

Motivational Interviewing and Physical Activity Change in Parkinson's Disease | Clinical Trials | Clareo Health

UNKNOWNNA

Motivational Interviewing and Physical Activity Change in Parkinson's Disease

NCT03329833•Shirley Ryan AbilityLab

Summary

The purpose of this study is to test the efficacy of a 6-month telephone-based motivational interviewing intervention and a web-based application intervention to improve physical activity in participants with Parkinson's Disease.

Detailed Description

Participants will be randomized into one of four groups to examine two separate interventions. The groups are: motivational interviewing (a counseling/coaching style), a web-based application for participants to keep track of their physical activity, a combination of the motivational interviewing and the web-based application, and an educational program on various issues related to Parkinson's Disease. The intervention will last 6 months with a follow-up appointment at 9 months. Participants will be asked to come to Galter Pavilion at Northwestern Memorial Hospital or Shirley Ryan AbilityLab a total of five times over the course of the nine months.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Community dwelling
•Age 18 or older
•Physician confirmed diagnosis of PD with Hoehn and Yahr stage ≤3
•Ability to ambulate independently (walker is allowed) for distance of 50 feet or 10 minutes at a time
•Does not meet current CDC physical activity guidelines of 150 minutes of moderate to vigorous physical activity per week
•Currently and plans to have a smartphone, tablet, or computer and access to the internet for the next 9 months
•Willing to monitor activity on their smartphone, tablet, or computer via a web-based application during the 9-month program
•Currently uses the internet in a basic capacity

Exclusion Criteria

•Inability to speak and understand English
•Has a cardiovascular disorder or other health condition that would make exercise unsafe according to their physician
•Patients who are currently receiving physical therapy or received physical therapy one month prior to study enrollment
•Cognitive impairment as defined by inability to provide informed consent and to self-report feelings and behaviors
•Montreal Cognition Scale (MOCA): rating of less than 24, indicative of cognitive dysfunction
•Patients who indicate it is not recommended they participate in increased physical activity as indicated by the Physical Activity Restriction Questionnaire (PAR-Q)
•Patients who are in other studies that monitor fitness or physical activity

Locations (2)

Northwestern Medicine

Chicago, Illinois, United States

Shirley Ryan Abilitylab

Chicago, Illinois, United States

Key Dates

Start Date

November 20, 2017

Primary Completion Date

April 30, 2021

Completion Date

April 30, 2021

Last Updated

October 14, 2020

Enrollment

ACTUAL participants

Conditions

Parkinson Disease

Interventions

Motivational Interviewing

BEHAVIORAL

Web-based application

BEHAVIORAL

[18F]F-DOPA Imaging in Patients With Autonomic Failure

NCT04246437

Autonomic FailurePure Autonomic Failure+3 more

View study

RECRUITINGNA

Characterizing the Pathophysiological Role of the Pallido-thalamocortical Motor Pathway in Parkinson's Disease.

NCT06692920

Parkinson Disease

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 14, 2020Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Motivational Interviewing and Physical Activity Change in Parkinson's Disease

Inclusion Criteria

Exclusion Criteria

[18F]F-DOPA Imaging in Patients With Autonomic Failure

Characterizing the Pathophysiological Role of the Pallido-thalamocortical Motor Pathway in Parkinson's Disease.

Montelukast in Parkinson Disease

Exercise for Cognitive Excellence in Parkinson's Disease

SAD Study in Patients With Parkinson's Disease and Motor Fluctuations

The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients